menu
    • menu

    Company profile for Stealth Biotherapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Stealth BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    275 Grove Street 3-107, Newton, MA 02466
    Telephone
    Telephone
    +617-600-6888
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.stealthbt.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Stealth Bio Unveils Mito Assist Program, Partners with AnovoRx
    Stealth Bio Unveils Mito Assist Program, Partners with AnovoRx

    09 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-mito-assist-patient-support-program-and-specialty-pharmacy-partnership-with-anovorx-to-distribute-forzinityelamipretide-injection-302579785.html

    PR NEWSWIRE
    09 Oct 2025
    Share Share
    US FDA Approves First Treatment for Rare Disease in Males
    US FDA Approves First Treatment for Rare Disease in Males

    20 Sep 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-treatment-rare-life-threatening-disease-males-2025-09-19/

    REUTERS
    20 Sep 2025
    Share Share
    Stealth Biotherapeutics`s Forzinity Receives Approval in US
    Stealth Biotherapeutics`s Forzinity Receives Approval in US

    19 Sep 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215244

    FDA
    19 Sep 2025
    Share Share
    Stealth, Barth Community Await FDA Verdict With All at Stake
    Stealth, Barth Community Await FDA Verdict With All at Stake

    16 Sep 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/stealth-barth-community-await-fda-verdict-with-everything-at-stake

    BIOSPACE
    16 Sep 2025
    Share Share
    Stealth's Flight Path Returns to FDA for Rejected Barth Drug
    Stealth's Flight Path Returns to FDA for Rejected Barth Drug

    23 Aug 2025

    // BIOSPACE

    https://www.biospace.com/fda/stealths-flight-path-returns-to-fda-for-rejected-barth-drug

    BIOSPACE
    23 Aug 2025
    Share Share
    Stealth Bio Submits Rare Disease Application for The Third Time
    Stealth Bio Submits Rare Disease Application for The Third Time

    19 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/stealth-biotherapeutics-resubmits-new-drug-application-for-elamipretide-for-the-treatment-of-barth-syndrome-302531219.html

    PR NEWSWIRE
    19 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search